Xiao-xia, G., Qin, Y., Ru-jia, X. et al. Effect of Danshao Huaxian capsule on the expression of collagen I, III, and caspase-3 in hepatic fibrosis rats., Chin. J. Integr. Med. 10, 289–295 (2004). https://doi.org/10.1007/BF02836432
Geng Xiao-xia, Yang Qin, Xie Ru-jia, et al. Effect of Danshao Huaxian capsule on the expression of collagen I, III, and caspase-3 in hepatic fibrosis rats[J]. Chinese Journal of Integrative Medicine, 2004,10(4):289-295.
Xiao-xia, G., Qin, Y., Ru-jia, X. et al. Effect of Danshao Huaxian capsule on the expression of collagen I, III, and caspase-3 in hepatic fibrosis rats., Chin. J. Integr. Med. 10, 289–295 (2004). https://doi.org/10.1007/BF02836432DOI:
Geng Xiao-xia, Yang Qin, Xie Ru-jia, et al. Effect of Danshao Huaxian capsule on the expression of collagen I, III, and caspase-3 in hepatic fibrosis rats[J]. Chinese Journal of Integrative Medicine, 2004,10(4):289-295. DOI: 10.1007/BF02836432.
Effect of Danshao Huaxian capsule on the expression of collagen I, III, and caspase-3 in hepatic fibrosis rats
摘要
Objective: To study the effect of Danshao Huaxian capsule (DSHX)
a traditional Chinese medical prescription
on the expression of collagen (Col) I
III and cysteinyl aspartate specific proteases-3 (caspase-3) in CCl4-induced hepatic fibrosis in rats. And also it is to explore the mechanism of DSHX in anti-fibrosis.Methods: Eighty male Wistar rats were randomly divided into the normal control group (A)
the model group (B)
the un-treated model group (C)
the low-dose-DSHX treated group (D) and the high-dose-DSHX treated group (E). Except those in Group A
all the other rats were made into hepatic fibrotic models by comprehensive processes including subcutaneous injecting of CCl4
and feeding them with alcoholic high-fat and low-protein diet for 8 weeks. Then the two DSHX-treated groups were treated respectively with low dose (0.5 g/kg) and high dose (1.0 g/kg) DSHX capsule by gastrogavage everyday for 8 weeks. At the end of the experiment
the liver index
levels of hyaluronic acid (HA) and alanine aminotransferase (ALT) in serum
degree of hepatic fibrosis
and urinary excretion of hydroxyproline (Hyp) were measured
and the expression of Col I
Col III and caspase-3 in liver tissues were detected respectively by immunohistochemistric technique.Results: Compared with those in Group B and C
the two DSHX treated groups showed that the liver index
levels of serum HA and ALT and severity of hepatic fibrosis were all significantly lower
the urinary excretion of Hyp was significantly higher; the Col I and Col-III expression was lower (Col I: 1.23±1.14
1.07 ±0.96 vs 4.18±2.26
3.22±1.44
P<0.01;Col III: 1.31±0.69
1.09±0.58 vs 3.04±0.62
2.23±0.58
P<0.05). At the same time
the expression of caspase-3 in Group E was fewer than Group B and C in hepatocytes (3.09±0.65 vs 9.60±2.32
8.82±1.45
P<0.01)
but it was extensively expressed in fibrous septal cells(4.52±0.87 vs 1.69±0. 23
2. 98±0. 36
P<0.01).Conclusion: DSHX capsule shows certain therapeutic effect on hepatic fibrosis in rats
and the mechanism might be related with reducing Col I and Col III deposition
inhibiting hepatocyte apoptosis and promoting fibrous septal cells (mainly the activated hepatic stellate cells) apoptosis.
Abstract
Objective: To study the effect of Danshao Huaxian capsule (DSHX)
a traditional Chinese medical prescription
on the expression of collagen (Col) I
III and cysteinyl aspartate specific proteases-3 (caspase-3) in CCl4-induced hepatic fibrosis in rats. And also it is to explore the mechanism of DSHX in anti-fibrosis.Methods: Eighty male Wistar rats were randomly divided into the normal control group (A)
the model group (B)
the un-treated model group (C)
the low-dose-DSHX treated group (D) and the high-dose-DSHX treated group (E). Except those in Group A
all the other rats were made into hepatic fibrotic models by comprehensive processes including subcutaneous injecting of CCl4
and feeding them with alcoholic high-fat and low-protein diet for 8 weeks. Then the two DSHX-treated groups were treated respectively with low dose (0.5 g/kg) and high dose (1.0 g/kg) DSHX capsule by gastrogavage everyday for 8 weeks. At the end of the experiment
the liver index
levels of hyaluronic acid (HA) and alanine aminotransferase (ALT) in serum
degree of hepatic fibrosis
and urinary excretion of hydroxyproline (Hyp) were measured
and the expression of Col I
Col III and caspase-3 in liver tissues were detected respectively by immunohistochemistric technique.Results: Compared with those in Group B and C
the two DSHX treated groups showed that the liver index
levels of serum HA and ALT and severity of hepatic fibrosis were all significantly lower
the urinary excretion of Hyp was significantly higher; the Col I and Col-III expression was lower (Col I: 1.23±1.14
1.07 ±0.96 vs 4.18±2.26
3.22±1.44
P<0.01;Col III: 1.31±0.69
1.09±0.58 vs 3.04±0.62
2.23±0.58
P<0.05). At the same time
the expression of caspase-3 in Group E was fewer than Group B and C in hepatocytes (3.09±0.65 vs 9.60±2.32
8.82±1.45
P<0.01)
but it was extensively expressed in fibrous septal cells(4.52±0.87 vs 1.69±0. 23
2. 98±0. 36
P<0.01).Conclusion: DSHX capsule shows certain therapeutic effect on hepatic fibrosis in rats
and the mechanism might be related with reducing Col I and Col III deposition
inhibiting hepatocyte apoptosis and promoting fibrous septal cells (mainly the activated hepatic stellate cells) apoptosis.
关键词
Liver Fibrosiscollagencysteinyl aspartate specific proteases-3apoptosistraditional Chinese herbs
Keywords
Liver Fibrosiscollagencysteinyl aspartate specific proteases-3apoptosistraditional Chinese herbs
references
Weng HL, Cai WM, Liu RH. Animal experiment and clinical study of effect of gamma 2 interferon on hepatic fibrosis. World J Gastroenterol 2001; 7: 42–48.
Li CX, Luo J, Li L, et al. The protective effects of Handan Ganle on CCl4-induced liver fibrosis in rats. Chin Public Health 1998; 14(9): 527–529.
Zhang HN, Li CX, Huang NH, et al. The preventive actions of traditional Chinese medicine Handan Ganle on immune liver fibrosis in rats. Guizhou Med J 2001; 25(5): 415–417.
Cheng ML, Ding YS, Luo YF, et al. The clinical research of the therapeutic effects of Handan Bituo on chronic active hepatitis. Chin J Integr Tradit West Med 1996; 16(7): 431–432.
Cheng ML, Yang CQ. The basic study and clinical research on hepatic fibrosis. Los Angeles: First Jumbo Publishing Co, 2002: 29–30.
Bissell DM. Connective tissue metabolism and hepatic fibrosis: an overview. Semin Liver Dis 1990; 10(1): iiiiv.
Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. J Gastroenterol 1997; 113(5): 1609–1614.
Zheng M, Cai WM, Weng HL, et al. ROC curve in evaluation of serum fibrosis index for diagnosing hepatic fibrosis. Chin J Infect Dis 2002; 20(4): 225–227.
Ding HB, Chen YP, Feng XR, et al. Correlation analysis between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B. Chin J Hepatol 2001; 9(2): 78–80.
Gao CF, Ye WM, Xu LL, et al. Application study of serum markers in the diagnosis of fibrotic liver disease. Chin J Lab Med 2001; 24(2): 91–93.
Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 1990; 10(1): 1–10.
Lu P, Luo HS, Yu BP. Hepatocellular apoptosis and its apoptosis-regulating gene in rat liver fibrosis model. World J Gastroenterol 2001; 9(2): 165–169.
Zhang HL, Wang WL, Hu LZ. Detection of the mutation of p53 and K-ras genes and their expression products. J Fourth Milit Med Univ 1999; 20(9): 769–771.
Nagata S. Apoptosis by death factor. Cell 1997; 88(3): 355–365.
Schulz JB, Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 1999; 45(4): 421–429.
Wolf BB, Schuler M, Echeverri F, et al. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem 1999; 274 (43): 30651–30656.
Tao J, Cai WM, Lu LW, et al. Expression of Bcl-2 and Bax proteins in rat liver fibrosis model and the role of IFN-γ. Chin J Hepatol 2003; 11(11): 669–672.
Issa R, Williams E, Trim N, et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 2001; 48 (4): 548–557.
Jiang CM, Liu C, Liu P. The developing researches of the HSC during liver fibrosis. Chin J Dig 2000; 20(4): 258–260.
Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol 1998; 29(5): 836–847
Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 1999;19(2): 129–140.
Williams EJ, Iredale JP. Liver cirrhosis. Postgrad Med J 1998; 74(870): 193–202.
Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000; 35(9): 665–672.
Wu YY, Cheng ML, Lu T, et al. Effect of Handan Ganle on the proliferation of fat-storing cell of mouse liver. Guizhou Med J 2000; 24(1): 15–16.
Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line
Apoptotic effect of cisplatin and cordycepin on OC3 human oral cancer cells
Xiayuxue Decoction (下瘀血汤) attenuates hepatic stellate cell activation and sinusoidal endothelium defenestration in CCl4-induced fibrotic liver of mice
The ethanol extract isolated from Weiqi Decoction (胃祺饮) induces G2/M arrest and apoptosis in AGS cells
Effects of Danshen Injection (丹参注射液) on inhibiting proliferation and inducing apoptosis through down-regulation of mutant JAK2 gene and its protein phosphorylation in human erythroid leukemic cells
相关作者
暂无数据
相关机构
Department of Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran
Department of Immunology, School of Medical Sciences, Tarbiat Modares University, Tehran
Department of Anesthesia, Chi-Mei Medical Center, Liouying, Tainan
Department of Nursing, Min-Hwei College of Health Care Management, Tainan
Division of Endocrinology and Metabolism, Kaohsiung Veteran General Hospital Tainan Branch, Tainan